OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Peter Nelson

1 Projects | 1 Researchers | $149,997 Invested

2014

University of Kentucky (P)

Peter Nelson, MD, PhD

Testing a novel therapeutic strategy for hippocampal sclerosis of aging, a common AD mimic

  • Funding Amount: $149,997
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed